PAVmed regains Nasdaq minimum bid price compliance after bid price recovered above $1

PAVmed Inc.

Nasdaq notified PAVmed on Jan 5, 2024 that it regained compliance with Rule 5550(a)(2).
Closing bid price was at or above $1 from Dec 7, 2023 through Jan 5, 2024.
Company had been deficient since Dec 29, 2022 when bid price fell below $1 for 30 consecutive days.

item 8.01 item 9.01

PAVmed Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-001710

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.